Pancreatic Cancer Research

ResearcherUniversity of Mississippi Medical CenterNo recent work listed

Lucio Miele

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-5853-7287; OpenAlex author ID A5041301571. Sources: OpenAlex.

Their work

Papers
9 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
13
Papers, trials and grants by year

2011: 4 papers · 2012: 3 papers · 2013: 1 paper · 2014: none · 2015: none · 2016: none · 2017: none · 2018: 1 paper

Papers 9

  1. Retraction notice to "Notch-1 induces Epithelial-mesenchymal transition consistent with cancer stem cell phenotype in pancreatic cancer cells". Co-author DOI 10.1016/j.canlet.2018.03.020↗
  2. Genistein down-regulates miR-223 expression in pancreatic cancer cells. Co-author DOI 10.2174/13894501113149990187↗
  3. Targeting pancreatic cancer stem cells for cancer therapy. Co-author DOI 10.1016/j.bbcan.2012.06.002↗
  4. Genistein inhibits cell growth and induces apoptosis through up-regulation of miR-34a in pancreatic cancer cells. Co-author DOI 10.2174/138945012804545597↗
  5. The Role of EMT in Pancreatic Cancer Progression. First author DOI 10.4172/2165-7092.1000e121↗
  6. Over-expression of FoxM1 leads to epithelial-mesenchymal transition and cancer stem cell phenotype in pancreatic cancer cells. Co-author DOI 10.1002/jcb.23150↗
  7. Notch-1 induces epithelial-mesenchymal transition consistent with cancer stem cell phenotype in pancreatic cancer cells. Co-author DOI 10.1016/j.canlet.2011.03.012↗
  8. Activated K-ras and INK4a/Arf deficiency cooperate during the development of pancreatic cancer by activation of Notch and NF-κB signaling pathways. Co-author DOI 10.1371/journal.pone.0020537↗
  9. Targeting notch to eradicate pancreatic cancer stem cells for cancer therapy. Co-author PMID 21508353↗

Closest collaborators

The 13 strongest of 13 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Fazlul H. Sarkar · 8 shared papers, 2011–2018 · strength 0.28
  2. Zhiwei Peter Wang · 5 shared papers, 2011–2018 · strength 0.19
  3. Yiwei Li · 5 shared papers, 2011–2018 · strength 0.18
  4. Asfar Sohail Azmi · 5 shared papers, 2011–2018 · strength 0.18
  5. Sanjeev Banerjee · 5 shared papers, 2011–2018 · strength 0.18
  6. Bin Bao · 5 shared papers, 2011–2018 · strength 0.18
  7. Shadan S. Ali · 4 shared papers, 2011–2018 · strength 0.15
  8. Jun Xia · 3 shared papers, 2012–2013 · strength 0.10
  9. Zhiwei Wang · 3 shared papers, 2011–2013 · strength 0.09
  10. Qiong Wu · 1 shared paper, 2012 · strength 0.06
  11. Jia Ma · 2 shared papers, 2012–2013 · strength 0.06
  12. Jiankun Gao · 1 shared paper, 2011 · strength 0.02
  13. Murray Korc · 1 shared paper, 2011 · strength 0.02

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.